KalVista Pharmaceuticals, Inc. KALV
Set alert
27.00 USD 0.00 0.00%
At close · Jun 10
26.99 -0.01 -0.04%
After hours · Jun 10, 4:00 PM ET
26.98 Day range 27.00
9.83 52-week range 27.00
- YTD
- +67.18%
- 1 year
- +106.26%
- Open
- 26.99
- Prev close
- 27.00
- Mkt cap
- 1.44B
- Vol
- 4.26M
- Avg vol
- 3.63M
- EPS
- -3.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.98
- High
- 27.00
- Forward P/E
- 15.82
- Beta
- -0.11
- Short ratio
- 0.94
- Inst. own
- 136.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 3, 2026
- 50-d avg
- 24.43
- 200-d avg
- 17.09
- 1y target
- 27.00
Analyst view
Consensus: hold
Hold
Price target (mean) 27.00
Ratings (0m) 5 0 buy · 5 hold · 0 sell
- Strong buy0
- Buy0
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 7
- 2 months ago 7
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.28667 | -0.43 – -0.02 | 0.00 | 0.0% | 49.18M | 0.0% | 6 |
| Next quarter | -0.27 | -0.92 – 0.25 | -0.91 | +70.3% | 58.50M | 0.0% | 6 |
| Current year | -0.878 | -1.70 – 0.59 | -2.03 | +56.8% | 213.46M | +334.9% | 5 |
| Next year | 1.55 | 0.44 – 3.81 | -0.878 | +276.0% | 348.38M | +63.2% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 1, 2026 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 30, 2026 | Needham | Downgrade | Buy | Hold |
| Mar 26, 2026 | Stifel | Maintained | Buy | Buy |
| Mar 26, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 25, 2026 | Needham | Maintained | Buy | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 9, 2026 | Needham | Maintained | Buy | Buy |
| Jan 6, 2026 | Needham | Maintained | Buy | Buy |
| Dec 4, 2025 | Needham | Reiterated | Buy | Buy |
| Nov 11, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Sep 12, 2025 | Needham | Reiterated | Buy | Buy |
| Sep 12, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 11, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 8, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2025 | Leerink Partners | Maintained | Outperform | Outperform |
| Apr 8, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 26, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 26, 2025 | Citizens Capital Markets | Reiterated | Market Outperform | Market Outperform |
| Mar 26, 2025 | Jones Trading | Maintained | Buy | Buy |
| Mar 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 3, 2025 | Citizens Capital Markets | Reiterated | Market Outperform | Market Outperform |
| Jan 31, 2025 | JMP Securities | Initiated | — | Market Outperform |
| Jan 7, 2025 | TD Cowen | Initiated | — | Buy |
| Dec 18, 2024 | B of A Securities | Initiated | — | Buy |
| Dec 9, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Dec 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 5, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |